tiprankstipranks

NeoGenomics price target lowered to $19 from $20 at TD Cowen

TD Cowen analyst Dan Brennan lowered the firm’s price target on NeoGenomics (NEO) to $19 from $20 and keeps a Buy rating on the shares. The firm said they posted a rare quarterly shortfall and combined with the CEO transition, sent the shares lower. Although results were mixed, they believe the share price decline seems to be an over reaction.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue